Russia's Sputnik V vaccine 91.6% effective — Lancet study
Russia's Sputnik V vaccine 91.6% effective — Lancet study By AFP - Feb 02,2021 - Last updated at Feb 02,2021 This handout file photo taken on August 6, 2020 and provided by the Russian Direct Investment Fund shows the vaccine against the coronavirus disease (Sputnik V), developed by the Gamaleya Research Institute of Epidemiology and Microbiology (AFP photo) PARIS — Russia's Sputnik V vaccine is 91.6 per cent effective against symptomatic COVID-19, according to results published in The Lancet on Tuesday that independent experts said allayed transparency concerns over the jab, which Moscow...